An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole (Q35942379)

11 August 2017

An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole (English)

1 reference

11 August 2017

0 references

invasive aspergillosis

1 reference

1 reference

A Gadisseur

5

0 references

author name string

F Jacobs

1

1 reference

11 August 2017

D Selleslag

2

1 reference

11 August 2017

M Aoun

3

1 reference

11 August 2017

A Sonet

4

1 reference

11 August 2017

language of work or name

1 reference

5 October 2011

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

11 August 2017

1 reference

11 August 2017

31

1 reference

11 August 2017

6

1 reference

11 August 2017

1173-1179

1 reference

Creative Commons Attribution-NonCommercial 2.0 Generic

11 August 2017

start time

5 October 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

In vitro activity of antifungals against Zygomycetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Invasive fungal infections: a review of epidemiology and management options

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Aspergillosis case-fatality rate: systematic review of the literature

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

A comparison of observational studies and randomized, controlled trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

What observational studies can offer decision makers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Management and outcome of bloodstream infections due to Candida species in England and Wales

2 October 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1425-5

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1425-5

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1425-5

Voriconazole treatment of invasive aspergillosis: real-world versus health-economic model results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1425-5

Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1425-5

Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1425-5

Clinical use and tolerability of voriconazole in the treatment of fungal infections in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1425-5

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Economic effects of aspergillosis management in high-risk patients.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Recommendations for the treatment of established fungal infections

24 September 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1425-5

Invasive aspergillosis in patients with solid tumors

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21971820

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Invasive Pulmonary Aspergillosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21971820

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10096-011-1425-5

1 reference

release_5nm4fgsyifdvpk525geuxfma6u

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5nm4fgsyifdvpk525geuxfma6u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

11 August 2017

PubMed publication ID

21971820

1 reference